|
1
|
Zhang Z, Pan J, Li L, Wang Z, Xiao W and
Li N: Survey of risk factors contributed to lymphatic metastasis in
patients with oral tongue cancer by immunohistochemistry. J Oral
Pathol Med. 40:127–134. 2011.
|
|
2
|
Nagabhushan Kalburgi S, Khan NN and Gray
SJ: Recent gene therapy advancements for neurological diseases.
Discov Med. 15:111–119. 2013.
|
|
3
|
Barbosa M, Henrique M, Pinto-Basto J,
Claes K and Soares G: Prostate cancer in Cowden syndrome: somatic
loss and germline mutation of the PTEN gene. Cancer Genet.
204:224–225. 2011.
|
|
4
|
Feng ZZ, Chen JW, Yang ZR, Lu GZ and Cai
ZG: Expression of PTTGI and PTEN in endometrial carcinoma:
correlation with tumorigenesis and progression. Med Oncol.
29:304–310. 2012.
|
|
5
|
Huang SH and O’Sullivan B: Oral cancer:
Current role of radiotherapy and chemotherapy. Med Oral Patol Oral
Cir Bucal. 18:e233–e240. 2013.
|
|
6
|
Vasko V, Espinosa AV, Scouten W, et al:
Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2808. 2007.
|
|
7
|
Tang CH and Tsai CC: CCL2 increases MMP-9
expression and cell motility in human chondrosarcoma cells via the
Ras/Raf/MEK/ERK/NF-κB signaling pathway. Biochem Pharmacol.
83:335–344. 2012.
|
|
8
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007.
|
|
9
|
Tshering Vogel DW, Zbaeren P and Thoeny
HC: Cancer of the oral cavity and oropharynx. Cancer Imaging.
10:62–72. 2010.
|
|
10
|
Yip KW, Li A, Li JH, et al: Potential
utility of BimS as a novel apoptotic therapeutic molecule. Mol
Ther. 10:533–544. 2004.
|
|
11
|
Keniry M and Parsons R: The role of PTEN
signaling perturbations in cancer and in targeted therapy.
Oncogene. 27:5477–5485. 2008.
|
|
12
|
Wu B, Wang X, Chi ZF, et al: Ursolic
acid-induced apoptosis in K562 cells involving upregulation of PTEN
gene expression and inactivation of the PI3K/Akt pathway. Arch
Pharm Res. 35:543–548. 2012.
|
|
13
|
Gu T, Zhang Z, Wang J, Guo J, Shen WH and
Yin Y: CREB is a novel nuclear target of PTEN phosphatase. Cancer
Res. 71:2821–2825. 2011.
|
|
14
|
Rachmiel A, Aizenbud D and Peled M:
Enhancement of bone formation by bone morphogenetic protein-2
during alveolar distraction: an experimental study in sheep. J
Periodontol. 75:1524–1531. 2004.
|
|
15
|
Liu H, Liang SL, Kumar S, Weyman CM, Liu W
and Zhou A: Statins induce apoptosis in ovarian cancer cells
through activation of JNK and enhancement of Bim expression. Cancer
Chemother Pharmacol. 63:997–1005. 2009.
|
|
16
|
Ou Y, Ma L, Ma L, Huang Z, Zhou W, Zhao C,
Zhang B, Song Y, Yu C and Zhan Q: Overexpression of cyclin B1
antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt
pathway in human esophageal squamous cell carcinoma cells. Cancer
Biol Ther. 14:45–55. 2013.
|
|
17
|
Ma WJ, Lv GD, Tuersun A, et al: Role of
microRNA-21 and effect on PTEN in Kazakh’s esophageal squamous cell
carcinoma. Mol Biol Rep. 38:3253–3260. 2011.
|
|
18
|
Iwatsuki M, Mimori K, Fukagawa T, et al:
The clinical significance of vimentin-expressing gastric cancer
cells in bone marrow. Ann Surg Oncol. 17:2526–2533. 2010.
|
|
19
|
Häyry V, Mäkinen LK, Atula T, et al: Bmi-1
expression predicts prognosis in squamous cell carcinoma of the
tongue. Br J Cancer. 102:892–897. 2010.
|
|
20
|
Pickhard AC, Margraf J, Knopf A, Stark T,
et al: Inhibition of radiation induced migration of human head and
neck squamous cell carcinoma cells by blocking of EGF receptor
pathways. BMC Cancer. 11:3882011.
|
|
21
|
Leslie NR, Yang X, Downes CP and Weijer
CJ: PtdIns(3,4,5) P(3)-dependent and -independent roles for PTEN in
the control of cell migration. Curr Biol. 17:115–125. 2007.
|
